Scarica l'app Stockscreener
6.75
1.89%
-0.13
Dopo l'orario di chiusura:
6.74
-0.010
-0.15%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TNGX Giù?
Forum
Previsione
Precedente Chiudi:
$6.88
Aprire:
$6.89
Volume 24 ore:
932.17K
Relative Volume:
0.33
Capitalizzazione di mercato:
$731.66M
Reddito:
$42.51M
Utile/perdita netta:
$-116.49M
Rapporto P/E:
-6.0268
EPS:
-1.12
Flusso di cassa netto:
$-120.82M
1 W Prestazione:
-1.60%
1M Prestazione:
+25.93%
6M Prestazione:
+122.04%
1 anno Prestazione:
-31.89%
Intervallo 1D:
$6.71
$7.00
Intervallo di 1 settimana:
$6.36
$7.14
Portata 52W:
$1.03
$12.02
Tango Therapeutics Inc Stock (TNGX) Company Profile
Nome
Tango Therapeutics Inc
Settore
Industria
Telefono
(857) 320-4900
Indirizzo
201 BROOKLINE AVENUE, BOSTON
Confronta TNGX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TNGX
Tango Therapeutics Inc
|
6.75 | 745.75M | 42.51M | -116.49M | -120.82M | -1.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-17 | Iniziato | Jefferies | Buy |
| 2024-04-04 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-02-12 | Iniziato | Piper Sandler | Overweight |
| 2023-12-08 | Iniziato | B. Riley Securities | Buy |
| 2022-10-20 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2021-09-20 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Tango Therapeutics Inc Borsa (TNGX) Ultime notizie
Will Tango Therapeutics Inc. stock benefit from AI tech trendsSuperior capital gains - jammulinksnews.com
Is Tango Therapeutics Inc. a good long term investmentFree Trading Strategy Suggestions - Autocar Professional
What analysts say about Tango Therapeutics Inc. stockTremendous growth potential - jammulinksnews.com
Tango Therapeutics Inc. Stock Analysis and ForecastMarket-beating returns - jammulinksnews.com
Optimistic Investors Push Tango Therapeutics, Inc. (NASDAQ:TNGX) Shares Up 31% But Growth Is Lacking - 富途牛牛
What drives Tango Therapeutics Inc. stock priceFree Consultation - jammulinksnews.com
Tango Therapeutics to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025 - GlobeNewswire
Will Tango Therapeutics Inc. stock benefit from interest rate changesMarket Timing Advice - Newser
How Tango Therapeutics Inc. stock performs during market volatilityFree Consultation - Newser
How high can Tango Therapeutics Inc. stock price go in 2025Daily Volume Leaders - Newser
Can Tango Therapeutics Inc Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com
Does Tango Therapeutics (TNGX) Have the Potential to Rally 75.89% as Wall Street Analysts Expect? - MSN
What makes Tango Therapeutics Inc. stock price move sharplySolid Return Trade Selections - Newser
Why Tango Therapeutics Inc. stock attracts strong analyst attentionFree Capital Growth Strategies - Newser
Tango Therapeutics (TNGX) Soars 5.96% on Strong Q2 Earnings - AInvest
Tango Therapeutics’ SWOT analysis: biotech stock’s potential in precision cancer therapies - Investing.com
Tango Therapeutics (TNGX) Moves 7.5% Higher: Will This Strength Last? - MSN
HC Wainwright Issues Optimistic Forecast for TNGX Earnings - Defense World
Tango Therapeutics, Inc.(NasdaqGM: TNGX) added to Russell 3000 Value Index - MarketScreener
H.C. Wainwright reiterates Buy rating on Tango Therapeutics stock - Investing.com
Tango Therapeutics Announces First Patient Dosed in Phase - GlobeNewswire
Tango Therapeutics Launches Groundbreaking Trial for Advanced Pancreatic and Lung Cancer Treatment - Stock Titan
Exchange Traded Concepts LLC Purchases 47,901 Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX) - Defense World
Tango Therapeutics (TNGX.O) Surges 7.5% Amid Quiet Fundamental Landscape - AInvest
Tango Therapeutics' Mysterious 7.5% Spike: What’s Behind the Move? - AInvest
Sarepta Therapeutics, KULR Technology Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Tango Therapeutics’ SWOT analysis: stock poised for growth amid clinical trials - Investing.com
Tango Therapeutics Inc Azioni (TNGX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):